Catharina Boehme: Chief Executive Officer
In her roles as Chief Medical Officer (CMO) and Head of the TB programme, Catharina was responsible for the clinical evaluation of new tools for diagnosis for TB, malaria and neglected diseases. She also oversaw FIND’s downstream activities, which focused on laboratory strengthening, in-country validation, and implementation. Catharina managed the R&D projects for several new point of care technologies and molecular diagnostic approaches, which required close interaction with the diagnostics industry, academia, and WHO.
In April 2015 Catharina became a member of the WHO Strategic and Technical Advisory Group (STAG-TB). From 2013 to 2018, she served as co-Chair of the New Diagnostics Working Group of the Stop TB Partnership.
Catharina has an extensive background in clinical evaluation and has managed over 30 early-stage trials, and five late-phase large-scale trials, including those for five diagnostic tools recently endorsed by WHO. She played a key role in FIND’s Xpert MTB/RIF feasibility, evaluation and implementation studies in 12 high-burden countries, with a focus on identifying ways to adapt the device for use in low-resource settings.
Prior to joining FIND in 2005, she worked as programme coordinator for the Department of Infectious and Tropical Diseases in Munich, Germany and established a TB research unit at Mbeya Medical Research Program in Tanzania.
Catharina holds a Doctor of Medicine degree in Internal Medicine (Ludwig Maximilians University Munich, Germany) and diplomas in Public Health (Charite, Berlin, Germany) and in Management & Leadership (University of Heidelberg, Germany).
Zachary Katz: Chief Access Officer
Zachary Katz joined FIND in September 2016. He was most recently the Senior Director of Diagnostic Services for the Clinton Health Access Initiative (CHAI), working to increase access to drugs and diagnostics for HIV, malaria, tuberculosis and other essential areas and playing an integral role in the introduction of new diagnostics for HIV. While at CHAI, Zach spearheaded a major effort to increase the use of point-of-care HIV diagnostics in seven high-burden countries, helping to create sustainable markets for those products. He also led in the conception and implementation of drastic global price reductions in HIV viral load and early infant testing, expected to save countries more than USD 150 million over five years.
Previously Zach held a number of in-country roles with CHAI, including Country Director of Papua New Guinea and Cambodia, and the Deputy Regional Directorship for Asia-Pacific.
Zach received his BA from Carleton College in the US and received an MPA from the Robert F. Wagner School of Public Service at New York University.
Rangarajan Sampath: Chief Scientific Officer
Dr Rangarajan Sampath joined FIND in September 2017. Prior to his role as Chief Scientific Officer at FIND, Ranga was the co-founder of Ibis Biosciences and a co-inventor of the IRIDICA (CE-IVD) infectious disease diagnostics platform.
Most recently, Ranga served as a Volwiler Senior Research Fellow and Senior Director of R&D for the Ibis Division of Abbott. He led Ibis’ efforts in infectious disease diagnostics, antimicrobial resistance diagnostics and surveillance and was responsible for applications development, validation, data analysis and reporting and scientific research for the Ibis PCR/ESI-MS based IRIDICA platform.
Ranga has been the lead investigator on several programs related to bioinformatics, drug discovery, and biological-warfare agent detection and treatment. He has extensive experience working with stakeholders across the healthcare continuum to being innovative technologies to scale.
With over 200 publications and presentations and over 40 patents in infectious disease diagnostics and its impact on patient management, Ranga’s research interests include antimicrobial strategy development, pathogen discovery, fevers of unknown origin, tropical diseases, epidemiological surveillance and biothreat detection.
Ranga earned a PhD in chemical engineering from Rice University in Houston, Texas in 1995 and a B. Tech in chemical engineering from the Indian Institute of Technology in Chennai, India, in 1989.
Jon Bastow: Director of Business Development & Resource Mobilization
As FIND’s Director of Business Development and Resource Mobilisation since May 2018, Jon builds mutually beneficial partnerships across the R&D and access landscape in IVD to help serve communities challenged by poverty-related diseases; whether it be partnerships with academia to encourage new technologies for our targeted diseases, collaborations to develop products across multiple clinical trial sites, or agreements around achieving broad access by combining value for money with maintenance and training. Jon is keen to evolve FIND’s approach to resource mobilization and embed donor partners early in the development and access strategies.
Jon brings 30 years of experience in healthcare, having worked in the pharmaceutical and diagnostics space in various roles across sales and marketing, product management and launch, project leadership, business development, market access, and strategic planning. During 5 years at the Global Fund, he channeled his passion to create significant and innovative partnerships with private sector healthcare and technology companies, NGOs, and governments, addressing some of the toughest problems of poverty through market-based solutions.
Jon is a chartered marketer and member of the Chartered Institute of Marketing. He holds degrees in Biochemistry and Philosophy and earned subsequent professional marketing qualifications. Jon has attended leadership and business courses and lectured at IMD, LBS, INSEAD and the Graduate Institute in Geneva and also encourages continuous improvement through workplace learning in himself and colleagues.
Louisa Chaubert: Director of Finance
Louisa qualified as a Chartered Accountant in 1991 after training in audit in the UK. She then worked in the tax department specializing in tax investigations and company taxation. In Switzerland, she set up an offshore audit practice before moving to the not for profit sector where she worked as Manager Controls and Procedures at WWF International developing and implementing financial systems.
She holds a UK Chartered Accountant qualification and a diploma in computer science.
Cassandra Kelly: Director of Emerging Threats
Dr Cassandra Kelly-Cirino joined FIND in May 2017 and is currently Director of Emerging Threats. She has over 20 years of experience working in Canadian and US public health and private sector settings. Cassandra began her career at the Canadian National Microbiology Laboratory working on emerging infectious diseases, including bacteria, viruses and prions.
In her 10-year tenure at the Wadsworth Center, New York State Department of Health, Cassandra served as the Deputy Director of the Biodefense Laboratory, a heavily regulated and accredited laboratory. During this time Cassandra also completed a PhD in Immunology and Infectious Diseases and developed vaccine and passive immunotherapeutic candidates for anthrax infections. She engaged national and international stakeholders in the development of public health policy for infectious diseases with a focus on emergency response and preparedness, developed novel diagnostic assays for multiple pathogens, and served as a development partner for commercial companies developing novel tools to combat infectious diseases.
Most recently, Cassandra served as Vice President, Infectious Diseases with DNA Genotek, a Canadian company known for its sample stabilization and collection technologies. In this role Cassandra was responsible for multiple initiatives to bring simple collection and stabilization solutions to the global public health and outbreak response fields, including a Tuberculosis product designed specifically for low and middle income countries.
Sharon Saacks: Director of Operations
Sharon Saacks joined FIND in May 2008. She is responsible for coordinating the organization’s operations internationally. Prior to joining FIND, Sharon worked as operations manager for a group of independent consultants who worked in the not-for-profit sector on international development. Sharon holds a Master degree in Biology from the University of the Witwatersrand in Johannesburg, South Africa.
Claudia Denkinger: Head of Tuberculosis
Dr Claudia Denkinger has been Head of FIND’s Tuberculosis programme since February 2014. Claudia completed her medical school training and doctoral thesis in immunology at the Julius-Maximilians University in Wuerzburg, Germany. She trained in internal medicine at the Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Boston and also was the chief medical resident there.
After her internal medicine training, Claudia completed a Master in Tropical Medicine and International Public Health as well as a Diploma in Tropical Medicine and Hygiene at the London School of Hygiene and Tropical Medicine. She has worked in non-governmental organizations in HIV and tuberculosis care in South Africa and South America.
After returning to the BIDMC for an infectious disease fellowship, Claudia went on to McGill University for a postdoctoral fellowship focused on tuberculosis epidemiology and impact assessment as well as mathematical modeling of tuberculosis diagnostics. She continues to hold a faculty appointment in the Division of Infectious Disease at the BIDMC, Harvard Medical School, Boston.
In October 2018, Claudia accepted the role of Co-Chair of the Stop TB Partnership’s New Diagnostics Working Group.
Sabine Dittrich: Head of Malaria & Fever
Dr Sabine Dittrich joined FIND in December 2015 to lead the work on non-malarial fevers and has been Head of the Malaria & Fever programme since January 2018. Combining the malaria and fever portfolios reflects Sabine’s passion for addressing holistically the burden of fever in tropical settings. She has a strong background in malaria and non-malarial research and has spent five years in the Lao PDR as a principle investigator with the University of Oxford studying non-malarial fevers, particularly bacterial vector-borne infections, and evaluating and developing innovative diagnostic tools in a hospital setting in South East Asia.
Sabine completed a PhD at the University of Manchester (UK) studying the folate pathway of the malaria parasite and subsequently completed a fellowship with the European CDC on public health microbiology (EPIET/EUPHEM), based at the Dutch National Institute of Public Health. She has published extensively in the field of malaria and non-malarial fevers with NEJM, Lancet GH, EID, Malaria Journal and other relevant journals.
Jennifer Kealy: Head of Clinical & Regulatory Affairs
Jennifer Kealy, Head of Clinical and Regulatory Affairs at FIND, joined the organization in July 2017. She has 25 years’ experience in drug, vaccine and diagnostics R & D, for cardiovascular medicine, oncology, neurology, and infectious diseases. She began her career as an analytical chemist with Roche, transitioned into business development and then clinical research where she has held roles in project management, QA, monitoring and training.
Prior to joining FIND, Jennifer was Head of Quality Management Services and Senior Project Leader at the Swiss Tropical & Public Health Institute where she facilitated the development of vaccines against malaria and Ebola, managed an MDR TB trial in Uzbekistan and supported an MDA trial for LF in Indonesia.
From 2009-2013, Jennifer worked with the World Health Organization to build research capacity in Liberia as part of an onchocerciasis study and also worked with NIDIAG to assess and compare the accuracy of different diagnostic methods for neglected tropical diseases in Cambodia and Nepal.
Her experience includes collaborations with numerous biopharmaceutical companies, CROs, academic partners and NGOs, including the London School of Hygiene & Tropical Medicine, University of Antwerp, DNDi and Médecins Sans Frontières.
Jennifer holds an MPH (Erasmus University) and a BSc in Biochemistry (University of Minnesota). She is a lecturer at the University of Basel, University of Geneva, DIA and ECPM.
Sarah-Jane Loveday: Head of Communications
Sarah-Jane Loveday joined FIND in 2017 as Head of Communications. She has over 18 years of experience in healthcare communications spanning both the public and private sectors. Prior to joining FIND, she co-led the healthcare team at Weber Shandwick Geneva, a leading global public relations agency and also spent four years at the biotech company Merck Serono.
Sarah-Jane began her career in journal publishing and trained as a medical editor. She has extensive experience in all aspects of communications strategy and planning, including public relations, digital engagement, medical education, and scientific event management.
Sarah-Jane is a Certified Medical Publications Professional. She holds a BSc(Hons) from City University, London (UK) and a master’s degree from Royal Holloway, University of London (UK).
Béatrice Mouton: Head of Human Resources
After earning a BA in International Relations, followed by a Master’s degree in Development and Cooperation from the Sorbonne in Paris, she joined CEVEO, a start-up supported by “Vets without frontiers”, as Administrative Officer. Béatrice set up all administration for the new entity and wrote a business plan to raise funds before being promoted as Human Resources and Finance Officer to set up liaison offices in Eastern Europe, Central Asia and Vietnam, in addition to re-defining their policies.
In August 2001, Béatrice joined Médecins Sans Frontières, first as an expatriate in Dagestan and Russia as HR Manager and Administration, and then as Finance Controller with the Geneva-based Access Campaign.
With MSF Geneva, she was part of the creation of DNDi in May 2003 as Head of Human Resources for their Swiss headquarters and regional offices.
From 2003 to 2016, Béatrice developed and implemented the Human Resources strategy linked to DNDi’s strategic plan, rolled out a performance and career management system, and provided coaching to high-level staff on key HR issues.
In 2009, Béatrice received a Master degree in Human Resources from the University of Geneva. She joined FIND in June 2016.
Joseph Ndung'u: Head of NTD
Professor Joseph Ndung’u joined FIND in May 2006 to establish the human African trypanosomiasis (HAT) programme. In April 2011, the programme was renamed Neglected Tropical Diseases (NTD), for it now included Leishmaniasis, Chagas disease, Buruli ulcer, Schistosomiasis, and Soil-Transmitted Helminthiases (STH).
Joseph has a degree in veterinary medicine and surgery (BVM) from the University of Nairobi, and a PhD in the immunopathology of HAT (sleeping sickness) from the University of Glasgow’s Veterinary School in Scotland. He became a Visiting Professor of the University in 2001, and has held a similar position at the University of Wisconsin, Madison, USA. In 2013, he became a Corresponding Fellow of the Royal Society of Edinburgh (CorrFRSE).
In February 2019, Kenya’s President, Uhuru Kenyatta, named Joseph Chancellor of Jomo Kenyatta University of Agriculture and Technology for a period of five years, effective from 11 January 2019.
Piero Olliaro: Head of AMR Dx Use Accelerator
Piero Olliaro joined FIND in 2018 and currently leads the Antimicrobial Resistance Diagnostics Use Accelerator, a platform combining clinical and behaviour change initiatives that will inform policy for AMR. He is also Director of Science, International Severe Acute Respiratory and Emerging Infection Consortium, University of Oxford. Previously, he was head of Intervention and Implementation at the Special Programme on Research and Training in Tropical Diseases (TDR), WHO, Geneva.
Piero is an MD with post-graduate work in infectious diseases (Pavia, IT), a PhD (Pavia), an HDR-Habilitation à Diriger les Recherches (Grenoble), and an MA (Oxford). He is Membre Etranger de l’Académie de Médecine, France and has been a visiting professor with the University of Oxford since 2001. He has authored 342 peer-reviewed articles and numerous other documents.
Stefano Ongarello: Head of Data Services & Biobanking
Stefano Ongarello joined FIND in May 2015, becoming Head of Data Services & Biobanking in November 2017. He graduated in Computer Science Engineering from the University of Padova, Italy, and later obtained his PhD in Bioengineering from the same university, focusing on the development of statistical methods for the analysis of high dimensional genomic and proteomic data. Stefano was subsequently involved in European research programs aimed at improving the early detection of prostate cancer, combining the results of traditional assays with those obtained via high-throughput technologies. He worked for many years in the pharmaceutical industry, focusing on the analysis of biomarker data that contributed to drug development in diverse therapeutic areas including oncology, rheumatology, and fertility.
Prior to joining FIND, Stefano was Director of Biometrics at Quartz Bio, a clinical bioinformatics company, where he focused on the realization of personalized medicine for his customers’ clinical development programs. He joined FIND in May with the mission of providing statistical support in several disease areas, with a strong focus on HIV/AIDS to improve the characterization of diagnostic assays and to contribute to refining the methodology to estimate the incidence and prevalence of the disease.
Heidi Albert: Head of FIND South Africa
Dr Heidi Albert obtained a Bachelor of Pharmacy and Pharmacology Honours degree and PhD at the University of Bath, UK, before moving into a research career in diagnostics. She has more than 15 years of experience in TB diagnostics development and implementation in low resource settings. Heidi led the team responsible for the development of commercial rapid phage-based assays for diagnosis and drug susceptibility testing in a UK biotechnology company, working within the Tuberculosis Reference Laboratory at the South African Institute for Medical Research, Johannesburg, South Africa (now National Health Laboratory Service) and later in Cape Town, South Africa. She completed a Masters of Public Health, specializing in Health Economics, at the University of Cape Town.
Heidi joined FIND in March 2007 to oversee demonstration projects for rapid screening of multidrug-resistant TB in South Africa, in collaboration with the South Africa Medical Research Council, the National Health Laboratory Service, and the national and provincial departments of health. In April 2008 she moved to Uganda to establish FIND’s Diagnostics Research Laboratory based at the National TB Reference Laboratory in Kampala. While at FIND’s Uganda office, she conducted studies aimed at improving and simplifying specimen processing, as well as clinical studies of new technologies, including LED fluorescence microscopy, line probe assays, and Xpert MTB/RIF.
In July 2010, Heidi returned to South Africa where she worked on several projects implementing new diagnostic solutions in Southern Africa. In 2012, she became the Principal Investigator for FIND’s CDC-funded Cooperative agreement, “Building Global Capacity for Diagnostic Testing of Tuberculosis, Malaria and HIV through Laboratory Strengthening and Integration of Services under the President’s Emergency Plan for AIDS Relief (PEPFAR)”. This project currently supports diagnostic implementation and laboratory strengthening activities in 13 countries in Africa, Asia, and the Caribbean.
Heidi is currently serving on the Core Group of the Global Laboratory Initiative, a working group of the Stop TB Partnership.
Sanjay Sarin: Head of FIND India
Dr Sanjay Sarin joined FIND in September 2015 as Head of Country Operations for India and Head of Access Programme for Asia Pacific. He has a doctorate from PGIMER, Chandigarh, India and close to 20 years’ experience in health policy, market development, and business management with a specialization in the development of strategic initiatives for driving access in emerging markets. In his current role, he is responsible for providing leadership for strategic plan development and implementation of current and planned operations in FIND India, ensuring continued engagement with partners and donors at local and international levels and leading the resource mobilization efforts in the AP region.
Sanjay joined FIND from Becton Dickinson (BD), where he was Regional Director of Global Health for the Asia Pacific region and was responsible for design, development, and implementation of BD’s public health strategies. During his stint with BD, he was instrumental in establishing several key partnerships, including one with MoH India resulting in expansion of TB diagnostic capacity within the India NTP, TB lab strengthening partnership with USAID in Indonesia, and collaboration with Project Hope to strengthen diabetes management capacity at Class 1 facilities in China. Prior to that, Sanjay led the pre-analytical strategic business unit for BD in South Asia.
Before joining BD, Sanjay served as Regional Lab Advisor (India & South East Asia) with the Clinton Health Access Initiative (CHAI). At CHAI, he played a key role in scaling up access to CD4 monitoring within India’s AIDS Control Programme and was responsible for setting up more than a dozen functional CD4 laboratories apart from contributing to lab systems strengthening in high HIV burden countries of South East Asia and Africa.
In December 2018, Sanjay was selected to be a member of the newly constituted WHO SEAR rGLC (South East-Asia Region regional Green Light Committee), a regional advisory committee on MDR-TB. He will be a member from January 2019 to December 2020.
Sarabjit Chadha: Regional Technical Director, India
Dr Sarabjit S Chadha joined FIND India in September 2018 as the Regional Technical Director, FIND for the India and South-East Asia region. He is a clinician by training, with over 15 years of experience in clinical and programmatic management of Tuberculosis (TB), including drug-resistant TB. His other areas of expertise and interest are vector-borne diseases, infection control, and health system strengthening. Earlier he was Deputy Regional Director of the South-East Asia office of The Union, where he headed the TB and Communicable Diseases Unit.
In December 2018, Sarabjit was elected as the Chair of the Global Drug-resistant TB Initiative (GDI) Core Group in December 2018. From 2016-2018 he was the Chair of the WHO Regional Drug-Resistant TB Advisory Group for the South East Asian Region. He is also co-Chair of the TB and Prison sub-group of The Union. Sarabjit provides technical assistance on the management of drug-resistant TB to several countries in the region, including Bhutan, Bangladesh, India, Indonesia, Myanmar, Nepal, Sri Lanka, India, Indonesia, and Timor Leste. He facilitates international courses on Clinical Management of Drug-Resistant TB; TB Prevention and Care; and TB Operational Research. He has over 40 publications in international peer-reviewed journals.
Yen Nguyen: Representative of FIND Viet Nam, Programme Coordinator
Since she joined FIND in December 2011, Yen has been closely involved in the implementation of several projects, including EXPAND-TB, the FIND-CDC Cooperative Agreement and American Society for Clinical Pathology (ASCP) subcontract under the Global Fund, and recently Unlocking the Hepatitis C Diagnostics and Treatment Market.
After FIND received the Certificate of Operations from the Viet Nam Ministry of Foreign Affairs in August 2015, Yen has served as Representative of FIND in the country and currently is also serving as Programme Coordinator in Viet Nam.
Yen holds a Bachelor Degree in English Language Teaching and International Business Economics. Due to her keen interest in public health, she completed supplementary courses in this field and is currently enrolled in a Master programme in Public Health at Thang Long University, Hanoi, Vietnam.